Bioretec Oy Sets 70%+ Adjusted Gross Margin Target, Switches Reporting Method
Bioretec Oy updates 2026‑2028 sales‑margin targets to >70% adjusted gross margin and shifts to AGM reporting, offering clearer profit insight for investors.
2 minutes to read


